Thiard News@F4F

@newsen.bsky.social

1 month ago

Pierre Fabre Pharmaceuticals Advances Regulatory Discussion with FDA on Tabelecleucel for Critical Cancer Treatment Pierre Fabre Pharmaceuticals is moving forward with a Type A meeting with the FDA regarding the biologic license application for Tabelecleucel, aimed at treating relapsed EBV-positive PTLD.

Pierre Fabre Pharmaceuticals Advances Regulatory Discussion with FDA on Tabelecleucel for Critical Cancer Treatment #USA #FDA_Approval #Tabelecleucel #Pierre_Fabre #Secaucus,_NJ

Thiard News@F4F

@newsen.bsky.social

1 month ago

Pierre Fabre Laboratories Leverages AI for Innovative Dermo-Cosmetic Clinical Trials Pierre Fabre Laboratories, in collaboration with BotDesign, is pioneering the use of AI to enhance clinical studies in dermo-cosmetics, especially for acne treatments.

Pierre Fabre Laboratories Leverages AI for Innovative Dermo-Cosmetic Clinical Trials #France #Toulouse #Pierre_Fabre #Avène #BotDesign

Thiard News@F4F

@newsen.bsky.social

1 month ago

Exploring AI's Role in Clinical Studies for Dermo-Cosmetics by Pierre Fabre Laboratories Discover how Pierre Fabre Laboratories is harnessing AI technology to enhance clinical studies in dermo-cosmetics, launching innovative treatments for acne.

Exploring AI's Role in Clinical Studies for Dermo-Cosmetics by Pierre Fabre Laboratories #France #Artificial_Intelligence #Toulouse #Pierre_Fabre #Avène

Thiard News@F4F

@newsen.bsky.social

1 month ago

Pierre Fabre Pharmaceuticals Pursues Accelerated Approval for Tabelecleucel with FDA Meeting Request Pierre Fabre Pharmaceuticals announces a Type A meeting request with the FDA regarding Tabelecleucel for treating EBV-positive PTLD, highlighting urgent patient needs.

Pierre Fabre Pharmaceuticals Pursues Accelerated Approval for Tabelecleucel with FDA Meeting Request #United_States #Secaucus #Tabelecleucel #EBV+_PTLD #Pierre_Fabre

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pierre Fabre Pharmaceuticals Faces Setback With FDA's Complete Response Letter on Tabelecleucel Application Pierre Fabre Pharmaceuticals has received a Complete Response Letter from the FDA regarding their Tabelecleucel application. They express disappointment amid a dire patient need.

Pierre Fabre Pharmaceuticals Faces Setback With FDA's Complete Response Letter on Tabelecleucel Application #United_States #FDA_Approval #Secaucus #Tabelecleucel #Pierre_Fabre

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pierre Fabre Laboratories and Iktos Collaborate on AI-Driven Drug Discovery for Oncology Pierre Fabre Laboratories and Iktos have announced a groundbreaking collaboration aimed at integrating AI for drug discovery in oncology, focusing on developing new low-molecular-weight drug candidates.

Pierre Fabre Laboratories and Iktos Collaborate on AI-Driven Drug Discovery for Oncology #France #Pierre_Fabre #Iktos #oncology_research #Castres

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pierre Fabre and Iktos Join Forces for AI-Driven Oncology Drug Discovery Pierre Fabre Laboratories collaborates with Iktos to accelerate drug discovery in oncology using AI, showcasing their commitment to advancing cancer research.

Pierre Fabre and Iktos Join Forces for AI-Driven Oncology Drug Discovery #France #Pierre_Fabre #AI_Drug_Discovery #Iktos #Castres

サードニュース@相互フォロー100%

@new3rd.bsky.social

3 months ago

Pierre FabreとIktosががん治療に向けたAIベースの提携を発表 Pierre Fabre LaboratoriesとIktosが、がん分野に特化したAI駆動の創薬提携を結びました。この革新的な連携により、治療薬の開発が加速し、がん患者に新たな希望をもたらすことが期待されています。

Pierre FabreとIktosががん治療に向けたAIベースの提携を発表 #がん治療 #Iktos #Pierre_Fabre

Pierre Fabre LaboratoriesとIktosが、がん分野に特化したAI駆動の創薬提携を結びました。この革新的な連携により、治療薬の開発が加速し、がん患者に新たな希望をもたらすことが期待されています。

Thiard News@F4F

@newsen.bsky.social

3 months ago

New AI-Powered Collaboration for Drug Discovery in Oncology Between Pierre Fabre and Iktos Pierre Fabre Laboratories and Iktos have formed a cutting-edge AI-focused collaboration aimed at enhancing drug discovery in oncology, utilizing advanced generative design technology.

New AI-Powered Collaboration for Drug Discovery in Oncology Between Pierre Fabre and Iktos #France #oncology #Pierre_Fabre #Iktos #Castres

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pierre Fabre and Iktos Join Forces to Revolutionize Cancer Drug Discovery with AI Pierre Fabre and Iktos announce a groundbreaking collaboration leveraging AI for drug discovery in oncology, enhancing treatment options for patients.

Pierre Fabre and Iktos Join Forces to Revolutionize Cancer Drug Discovery with AI #France #Pierre_Fabre #AI_Drug_Discovery #Iktos #Castres

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pierre Fabre and Iktos Partner for AI-Driven Cancer Drug Discovery Initiative Pierre Fabre Laboratories and Iktos have joined forces to leverage AI in oncology to accelerate drug discovery, marking a significant advancement in cancer research.

Pierre Fabre and Iktos Partner for AI-Driven Cancer Drug Discovery Initiative #France #oncology #Pierre_Fabre #Iktos #Castres

Thiard News@F4F

@newsen.bsky.social

4 months ago

Pierre Fabre Pharmaceuticals Presents Phase 3 Study Findings on Tabelecleucel for EBV+ PTLD at ASH Pierre Fabre Pharmaceuticals shared critical Phase 3 data on tabelecleucel for EBV+ PTLD at the ASH meeting, indicating safety and efficacy.

Pierre Fabre Pharmaceuticals Presents Phase 3 Study Findings on Tabelecleucel for EBV+ PTLD at ASH #USA #Secaucus #Tabelecleucel #EBV+_PTLD #Pierre_Fabre

Thiard News@F4F

@newsen.bsky.social

5 months ago

Pierre Fabre Pharmaceuticals Takes Charge of Tabelecleucel for an EBV+ PTLD Treatment Pierre Fabre Pharmaceuticals has now assumed responsibility for the BLA of Tabelecleucel, a potential breakthrough treatment for EBV+ PTLD, with FDA priority review expected soon.

Pierre Fabre Pharmaceuticals Takes Charge of Tabelecleucel for an EBV+ PTLD Treatment #United_States #Secaucus #Tabelecleucel #EBV+_PTLD #Pierre_Fabre

Thiard News@F4F

@newsen.bsky.social

6 months ago

The Empowering Partnership Between Eau Thermale Avène and Breast Cancer Alliance Eau Thermale Avène enhances breast cancer support through donations and skincare, collaborating with Breast Cancer Alliance for patient care.

The Empowering Partnership Between Eau Thermale Avène and Breast Cancer Alliance #None #Pierre_Fabre #Eau_Thermale_Avène #Breast_Cancer_Alliance

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pierre Fabre Laboratories Partners with Know Your Lemons Foundation for Global Breast Cancer Awareness Pierre Fabre Laboratories has launched a global initiative with Know Your Lemons Foundation to promote breast cancer awareness and education during October.

Pierre Fabre Laboratories Partners with Know Your Lemons Foundation for Global Breast Cancer Awareness #France #Pierre_Fabre #breast_cancer_awareness #Castres #Know_Your_Lemons

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pierre Fabre Laboratories and Know Your Lemons Partner for Breast Cancer Awareness Month In honor of Breast Cancer Awareness Month, Pierre Fabre Laboratories is teaming up with Know Your Lemons to promote early detection and education.

Pierre Fabre Laboratories and Know Your Lemons Partner for Breast Cancer Awareness Month #France #Breast_Cancer #Pierre_Fabre #Castres #Know_Your_Lemons

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pierre Fabre Laboratories Teams Up with Know Your Lemons Foundation for Breast Cancer Awareness Month Pierre Fabre Laboratories announces a global initiative with the Know Your Lemons Foundation for Breast Cancer Awareness Month, focusing on education and early detection.

Pierre Fabre Laboratories Teams Up with Know Your Lemons Foundation for Breast Cancer Awareness Month #France #Breast_Cancer #Pierre_Fabre #Castres #Know_Your_Lemons

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pierre Fabre Laboratories Partners with Know Your Lemons Foundation for Breast Cancer Awareness Month Pierre Fabre Laboratories teams up with the Know Your Lemons Foundation for a global campaign promoting early breast cancer detection and education this October.

Pierre Fabre Laboratories Partners with Know Your Lemons Foundation for Breast Cancer Awareness Month #France #Breast_Cancer #Pierre_Fabre #Castres #Know_Your_Lemons

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pierre Fabre's Initiative with Know Your Lemons Foundation Promotes Breast Cancer Awareness Globally Pierre Fabre Laboratories announces a global campaign with Know Your Lemons Foundation, promoting breast cancer education and early detection throughout October.

Pierre Fabre's Initiative with Know Your Lemons Foundation Promotes Breast Cancer Awareness Globally #France #Breast_Cancer #Pierre_Fabre #Castres #Know_Your_Lemons

Thiard News@F4F

@newsen.bsky.social

8 months ago

Innovation in Oncology: Tabelecleucel's Path Towards FDA Approval for EBV+ PTLD Treatment Pierre Fabre Pharmaceuticals is advancing the treatment landscape with Tabelecleucel, an innovative therapy for EBV+ PTLD, now under FDA review.

Innovation in Oncology: Tabelecleucel's Path Towards FDA Approval for EBV+ PTLD Treatment #United_States #Secaucus #Tabelecleucel #EBV+_PTLD #Pierre_Fabre

Thiard News@F4F

@newsen.bsky.social

8 months ago

Pierre Fabre Pharmaceuticals Takes Charge of Tabelecleucel Clinical Program for EBV+PTLD Pierre Fabre Pharmaceuticals has assumed responsibility for the clinical trials of tabelecleucel, a promising treatment for EBV+PTLD, marking a significant advances in cancer therapeutics.

Pierre Fabre Pharmaceuticals Takes Charge of Tabelecleucel Clinical Program for EBV+PTLD #USA #Secaucus #Tabelecleucel #Pierre_Fabre #EBV+PTLD

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pierre Fabre Laboratories Launches New US Office in Secaucus, NJ for Growth in Dermo-Cosmetics Pierre Fabre Laboratories inaugurates its US office in Secaucus, NJ, enhancing its commitment to the dermo-cosmetics and medical care markets.

Pierre Fabre Laboratories Launches New US Office in Secaucus, NJ for Growth in Dermo-Cosmetics #USA #Secaucus #Pierre_Fabre #Avène #Dermo-Cosmetics

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pierre Fabre Laboratories Expands R&D Portfolio with New Acquisition of PFL-721 and PFL-241 Rights Pierre Fabre Laboratories has successfully acquired global rights for PFL-721 and PFL-241, enhancing their R&D efforts in treating non-small cell lung cancer.

Pierre Fabre Laboratories Expands R&D Portfolio with New Acquisition of PFL-721 and PFL-241 Rights #France #Pierre_Fabre #Castres #PFL-721 #PFL-241

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pierre Fabre Laboratories Expands R&D Portfolio with New Drug Acquisitions Pierre Fabre Laboratories strengthens its R&D portfolio by acquiring worldwide rights for PFL-721 and PFL-241, promising new treatments for lung cancer.

Pierre Fabre Laboratories Expands R&D Portfolio with New Drug Acquisitions #France #Pierre_Fabre #Castres #PFL-721 #PFL-241

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pierre Fabre Laboratories Strengthens Its R&D Portfolio with Global Rights Acquisition Pierre Fabre Laboratories has announced the global acquisition of PFL-721 and PFL-241, enhancing its R&D portfolio for lung cancer treatments.

Pierre Fabre Laboratories Strengthens Its R&D Portfolio with Global Rights Acquisition #France #Pierre_Fabre #Castres #PFL-721 #PFL-241

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pierre Fabre Laboratories Expands R&D Portfolio with New Drug Acquisitions Pierre Fabre Laboratories has announced the acquisition of global rights for two promising cancer drugs, PFL-721 and PFL-241, enhancing their research portfolio.

Pierre Fabre Laboratories Expands R&D Portfolio with New Drug Acquisitions #France #Pierre_Fabre #Castres #PFL-721 #PFL-241

Thiard News@F4F

@newsen.bsky.social

9 months ago

Pierre Fabre Laboratories Expands R&D Portfolio with Key Acquisitions Pierre Fabre Laboratories has successfully acquired the worldwide rights for PFL-721 and PFL-241, promising solutions for non-small cell lung cancer, enhancing its R&D capabilities significantly.

Pierre Fabre Laboratories Expands R&D Portfolio with Key Acquisitions #France #Pierre_Fabre #Castres #PFL-721 #PFL-241

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pierre Fabre Laboratories and RedRidge Bio Team Up for Innovative Drug Development Partnership Pierre Fabre Laboratories and RedRidge Bio have entered a strategic drug discovery partnership aimed at advancing oncology and rare diseases treatments, showcasing their commitment to innovation.

Pierre Fabre Laboratories and RedRidge Bio Team Up for Innovative Drug Development Partnership #France #Pierre_Fabre #RedRidge_Bio #Castres #Bio_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pierre Fabre Laboratories and RedRidge Bio Form Drug Discovery Partnership to Target Precision Oncology Pierre Fabre Laboratories and RedRidge Bio have announced an exclusive partnership focused on drug discovery and development, emphasizing oncology and rare diseases.

Pierre Fabre Laboratories and RedRidge Bio Form Drug Discovery Partnership to Target Precision Oncology #France #Drug_Development #Pierre_Fabre #RedRidge_Bio #Castres

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pierre Fabre Laboratories and RedRidge Bio Forge Strategic Drug Development Alliance for Oncology and Rare Diseases Pierre Fabre Laboratories and RedRidge Bio have partnered for exclusive R&D in developing drug candidates focused on precision oncology and dermatology.

Pierre Fabre Laboratories and RedRidge Bio Forge Strategic Drug Development Alliance for Oncology and Rare Diseases #None #Drug_Discovery #Pierre_Fabre #RedRidge